AN ACT relating to ibogaine research in the Commonwealth.
Commonwealth of KentuckyKentuckyCreate new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.
- Status
- Passed
- Signed or otherwise enacted
- Status date
- Apr 14, 2026
- 212 days ago
- Current chamber
- House of Representatives
- Session
- 2026 Regular Session
Follow the legislation that affects what you sell.
Get started freeFree account · 30-second setup · No credit card
What it means for vendors
Civic IQ reads each bill for what it would fund, require or change for the agencies that buy.
Bill details
- Last action
- delivered to Secretary of State (Acts Ch. 158) · Apr 14, 2026
Sponsors
Bill history
Newest first.
Show 27 earlier actions
Recorded votes
Subjects
- Agriculture
- Appropriations
- Budget and Financial Administration
- Drugs and Medicines
- Effective Dates, Emergency
- Funds
- Opioids
- Public Health
- State Agencies
Read the bill at the source
This page follows the bill as the legislature records it. For the bill's full text and the official record, use the legislature's own site.
Bill data from LegiScan, licensed under CC BY 4.0.